Placebo Controlled Study of 3 Doses of Rifaximin-EIR Tablet to Treat Moderate, Active Crohn's Disease
Clinical trial NCT00528073 · COMPLETED
Trial details
- NCT number
- NCT00528073
- Sponsor
- Alfasigma S.p.A.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2009-03-01
- Enrollment
- 410
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.